Abstract
BackgroundMethotrexate (MTX) is the first line drug suggested in the ACR/EULAR guidelines to treat the rheumatoid arthritis (RA) (1) and spondylarthritis (SpA). Although MTX efficacy is demonstrated by high levels...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have